Cargando…
New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298198/ https://www.ncbi.nlm.nih.gov/pubmed/34724335 http://dx.doi.org/10.1111/jebm.12452 |
| _version_ | 1784750648751816704 |
|---|---|
| author | Xu, Xiang Bi, Yan |
| author_facet | Xu, Xiang Bi, Yan |
| author_sort | Xu, Xiang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9298198 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92981982022-07-21 New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks Xu, Xiang Bi, Yan J Evid Based Med Perspectives John Wiley and Sons Inc. 2021-11-01 2021-12 /pmc/articles/PMC9298198/ /pubmed/34724335 http://dx.doi.org/10.1111/jebm.12452 Text en © 2021 The Authors. Journal of Evidence‐Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Perspectives Xu, Xiang Bi, Yan New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks |
| title | New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks |
| title_full | New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks |
| title_fullStr | New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks |
| title_full_unstemmed | New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks |
| title_short | New way, new recommendation: Individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks |
| title_sort | new way, new recommendation: individualized treatment of novel antidiabetic drugs for people living with type 2 diabetes based on the cardiorenal risks |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298198/ https://www.ncbi.nlm.nih.gov/pubmed/34724335 http://dx.doi.org/10.1111/jebm.12452 |
| work_keys_str_mv | AT xuxiang newwaynewrecommendationindividualizedtreatmentofnovelantidiabeticdrugsforpeoplelivingwithtype2diabetesbasedonthecardiorenalrisks AT biyan newwaynewrecommendationindividualizedtreatmentofnovelantidiabeticdrugsforpeoplelivingwithtype2diabetesbasedonthecardiorenalrisks |